XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice

Active, not recruitingOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2024

Conditions
Percutaneous Transluminal Coronary AngioplastyCoronary Artery Disease
Interventions
DEVICE

XIENCE Xpedition/Alpine/Sierra

Trial Locations (26)

Unknown

Hallym University Sacred Heart Hospital, Anyang

Soon Chun Hyang University Hospital Bucheon, Bucheon-si

Soon Chun Hyang University Hospital Cheonan, Cheonan

Gangwon National Univ. Hospital, Chuncheon

Daegu Catholic University Medical Center, Daegu

Keimyung University Dongsan Medical Center, Daegu

Yeungnam University Medical Center, Daegu

The Catholic University of Korea, Daejeon ST. Mary's Hospital, Daejeon

Gangneung Asan Hospital, Gangneung

Chonnam National University Hospital, Gwangju

Gachon University Gil Hospital, Incheon

Inha University Hospital, Incheon

ChonBuk National University Hospital, Jeonju

Kwangju Christian Hospital, Kwangju

Dong-A Medical Center, Pusan

Inje University HAEUNDAE Paik Hospital, Pusan

Inje University Pusan Paik Hospital, Pusan

Pusan National University Hospital, Pusan

Asan Medical Center, Seoul

Korea University Guro Hospital, Seoul

Seoul Veterans Hospital, Seoul

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul

The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si

Ulsan University Hospital, Ulsan

Pusan National University Yangsan Hospital, Yangsan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

collaborator

Abbott

INDUSTRY

lead

Seung-Jung Park

OTHER